GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » E10

Merck (BUE:MRK) E10 : ARS845.35 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Merck E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Dec. 2024 was ARS14,948.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ARS845.35 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Merck's average E10 Growth Rate was 6.50% per year. During the past 3 years, the average E10 Growth Rate was 6.90% per year. During the past 5 years, the average E10 Growth Rate was 10.50% per year. During the past 10 years, the average E10 Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck was 15.90% per year. The lowest was -6.40% per year. And the median was 3.85% per year.

As of today (2025-03-04), Merck's current stock price is ARS21950.00. Merck's E10 for the quarter that ended in Dec. 2024 was ARS845.35. Merck's Shiller PE Ratio of today is 25.97.

During the past 13 years, the highest Shiller PE Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Merck E10 Historical Data

The historical data trend for Merck's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck E10 Chart

Merck Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.75 118.98 232.45 654.40 845.35

Merck Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 654.40 767.65 1,017.99 937.01 845.35

Competitive Comparison of Merck's E10

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=14948/133.1571*133.1571
=14,948.000

Current CPI (Dec. 2024) = 133.1571.

Merck Quarterly Data

per share eps CPI Adj_EPS
201503 29.105 99.621 38.903
201506 21.808 100.684 28.842
201509 60.175 100.392 79.815
201512 45.300 99.792 60.446
201603 58.416 100.470 77.421
201606 60.113 101.688 78.716
201609 116.351 101.861 152.099
201612 66.580 101.863 87.035
201703 86.335 102.862 111.762
201706 117.065 103.349 150.829
201709 -3.505 104.136 -4.482
201712 -61.747 104.011 -79.050
201803 54.402 105.290 68.801
201806 157.122 106.317 196.788
201809 268.633 106.507 335.851
201812 260.165 105.998 326.826
201903 437.808 107.251 543.562
201906 460.194 108.070 567.025
201909 413.852 108.329 508.702
201912 549.917 108.420 675.385
202003 782.073 108.902 956.264
202006 807.828 108.767 988.974
202009 861.184 109.815 1,044.237
202012 -675.454 109.897 -818.418
202103 1,126.000 111.754 1,341.646
202106 577.853 114.631 671.240
202109 1,760.040 115.734 2,024.999
202112 1,494.652 117.630 1,691.952
202203 1,825.325 121.301 2,003.734
202206 1,865.115 125.017 1,986.559
202209 1,778.560 125.227 1,891.196
202212 1,978.270 125.222 2,103.633
202303 2,192.805 127.348 2,292.835
202306 -5,640.000 128.729 -5,834.022
202309 6,509.070 129.860 6,674.359
202312 -1,732.800 129.419 -1,782.844
202403 15,754.750 131.776 15,919.846
202406 19,163.700 132.554 19,250.921
202409 11,786.199 133.029 11,797.557
202412 14,948.000 133.157 14,948.000

Add all the adjusted EPS together and divide 10 will get our e10.


Merck  (BUE:MRK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=21950.00/845.35
=25.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck E10 Related Terms

Thank you for viewing the detailed overview of Merck's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck Headlines

From GuruFocus